Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews Paul PosadzkiLeala WatsonEdzard Ernst Review Article 29 July 2012 Pages: 295 - 307
Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR) L. SoučkováR. OpatřilováV. Šrámek Review Article 14 August 2012 Pages: 309 - 317
Medication prescribing in frail older people Ruth E. HubbardM. Sinead O’MahonyKenneth W. Woodhouse Review Article 11 September 2012 Pages: 319 - 326
Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers Sebastian HärtterRegina SennewaldJeffrey Friedman Clinical Trial Open access 11 July 2012 Pages: 327 - 339
Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia Liliana GrigoreSara RaselliAlberico L. Catapano Clinical Trial 10 July 2012 Pages: 341 - 346
Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials Xavier CastellsRuth CunillDolors Capellà CLINICAL TRIAL 16 September 2012 Pages: 347 - 356
The out-of-focus bias in drug surveillance Markus GnädingerHans-Ulrich Mellinghoff Special Article 16 August 2012 Pages: 357 - 359
First reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confirmed recreational use of phenazepam Paul I. DarganSusannah DaviesDavid M. Wood Pharmacodynamics 29 July 2012 Pages: 361 - 363
Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: A placebo-controlled, ex vivo, serial placebo-controlled serial crossover study I. L. MeekH. E. VonkemanM. A. F. J. van de Laar Pharmacodynamics 14 August 2012 Pages: 365 - 371
First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201 David McQuadeSimon HudsonDavid M. Wood Pharmacodynamics 31 August 2012 Pages: 373 - 376
Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients Biljana JekicLjiljana LukovicMaja Krajinovic Pharmacogenetics 05 July 2012 Pages: 377 - 383
ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients Montserrat GarcíaRosa María MacíasGuillermo Gervasini Pharmacogenetics 11 August 2012 Pages: 385 - 393
Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population T. RusdianaT. ArakiK. Yamamoto Pharmacogenetics 02 August 2012 Pages: 395 - 405
Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers Yu ChengGuo WangHong-Hao Zhou Pharmacogenetics 28 July 2012 Pages: 407 - 413
Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population K. SubrajaS. A. DkharC. Adithan Pharmacogenetics 06 September 2012 Pages: 415 - 422
The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent Frances StringerGraham ScottRichard Urquhart Pharmacogenetics 09 September 2012 Pages: 423 - 430
Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn’s disease and ulcerative colitis Diana Lacruz-GuzmánDaniel Torres-MorenoPablo Conesa-Zamora Pharmacogenetics 08 September 2012 Pages: 431 - 438
Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin Sara K. QuinneySrikar R. MalireddyStephen D. Hall Pharmacokinetics and Disposition 10 July 2012 Pages: 439 - 448
Decreased vancomycin clearance in patients with congestive heart failure Yuko ShimamotoTsuyoshi FukudaKatsuya Komori Pharmacokinetics and Disposition 12 July 2012 Pages: 449 - 457
Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation A. RichardsonK. S. SakariassenA. S. Sorensen Pharmacokinetics and Disposition 20 July 2012 Pages: 459 - 465
VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation Milka MarinovaDieter LütjohannJohannes Oldenburg Pharmacokinetics and Disposition Open access 05 August 2012 Pages: 467 - 475
Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers Renli TengPatrick D. MitchellKathleen A. Butler Pharmacokinetics and Disposition 25 August 2012 Pages: 477 - 487
Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers Jun TanakaHidefumi KasaiYuji Kumagai Pharmacokinetics and Disposition Open access 24 August 2012 Pages: 489 - 497
Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach Sihem BenaboudSaïk UrienMarie Courbebaisse Pharmacokinetics and Disposition 31 August 2012 Pages: 499 - 506
Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity Ines FuchsVerena Hafner-BlumenstielGerd Mikus Pharmacokinetics and Disposition 12 September 2012 Pages: 507 - 513
Lack of effect of continuous glycyrrhizin administration on the pharmacokinetics of the P-glycoprotein substrate talinolol in healthy volunteers Miao YanPing-Fei FangQin-You Tan Pharmacokinetics and Disposition 15 September 2012 Pages: 515 - 521
Pharmacokinetic interactions of almorexant with midazolam and simvastatin, two CYP3A4 model substrates, in healthy male subjects Matthias HochPetra HoeverJasper Dingemanse Pharmacokinetics and Disposition 19 September 2012 Pages: 523 - 532
Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis P. H. CashinH. EhrssonH. Mahteme Pharmacokinetics and Disposition 16 September 2012 Pages: 533 - 540
In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children P. G. J. ter HorstH. J. BosB. Wilffert Pharmacoepidemiology and Prescription Open access 20 July 2012 Pages: 541 - 547
High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications E. GarbeS. KlossS. Schneeweiss Pharmacoepidemiology and Prescription 05 July 2012 Pages: 549 - 557
Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study L. H. Martín AriasC. TreceñoA. Carvajal Pharmacoepidemiology and Prescription 21 July 2012 Pages: 559 - 564
Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care M. L. AnderssonY. BöttigerB. Eiermann Pharmacoepidemiology and Prescription 01 July 2012 Pages: 565 - 571
Medication complexity, prescription behaviour and patient adherence at the interface between ambulatory and stationary medical care Dorit StangeLevente KristonDorothee C. Dartsch Pharmacoepidemiology and Prescription 25 July 2012 Pages: 573 - 580
Prescription drug dispensing profiles for one million children: a population-based analysis Tingting ZhangM. Anne SmithBruce C. Carleton Pharmacoepidemiology and Prescription 12 July 2012 Pages: 581 - 588
The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective Anton PottegårdBine Kjøller BjerregaardSøren Ilsøe Moreno Pharmacoepidemiology and Prescription 19 July 2012 Pages: 589 - 598
Methods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies Marco SequiRita CampiMaurizio Bonati Pharmacoepidemiology and Prescription 26 July 2012 Pages: 599 - 604
Methodology for a multinational case–population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT) Sinem Ezgi GulmezDominique LarreyNicholas Moore Pharmacoepidemiology and Prescription 10 August 2012 Pages: 605 - 616
Identification and weighting of the most critical “real-life” drug–drug interactions with acenocoumarol in a tertiary care hospital L. GschwindV. RollasonJ. A. Desmeules Pharmacoepidemiology and Prescription 19 August 2012 Pages: 617 - 627
Concurrent use of antiplatelets, anticoagulants, or digoxin with Chinese medications: a population-based cohort study Hsin-Hui TsaiHsiang-Wen LinTsai-Chung Li Pharmacoepidemiology and Prescription 09 August 2012 Pages: 629 - 639
Concurrent use of tramadol and oral vitamin K antagonists and the risk of excessive anticoagulation: a register-based nested case–control study Anton PottegårdPeter M. MeegaardJesper Hallas Pharmacoepidemiology and Prescription 31 July 2012 Pages: 641 - 646
In-hospital medication reviews reduce unidentified drug-related problems Åsa BondessonTommy ErikssonPeter Höglund Pharmacoepidemiology and Prescription 07 September 2012 Pages: 647 - 655
Potentially inappropriate drug use among older persons in Finland: application of a new national categorization J. Simon BellJouni AhonenSirpa Hartikainen Pharmacoepidemiology and Prescription 14 August 2012 Pages: 657 - 664
Different patterns in use of antibiotics for lower urinary tract infection in institutionalized and home-dwelling elderly: a register-based study Ylva HaasumJohan FastbomKristina Johnell Pharmacoepidemiology and Prescription 25 August 2012 Pages: 665 - 671
Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority Inês Ribeiro-VazJoana MarquesEva Rebelo Gomes Pharmacoepidemiology and Prescription 23 August 2012 Pages: 673 - 681
The association of ethnicity with electronically measured adherence to inhaled corticosteroids in children Erwin VasbinderNordin DahhanPatricia van den Bemt Pharmacoepidemiology and Prescription 07 September 2012 Pages: 683 - 690
Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case–control study in a new general practice database Francisco J. de AbajoMiguel J. GilLuis A. García-Rodríguez Pharmacoepidemiology and Prescription 06 September 2012 Pages: 691 - 701
Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention Beate Hennie GarciaLars SmåbrekkeTrude Giverhaug Pharmacoepidemiology and Prescription 19 September 2012 Pages: 703 - 709
Placebo? no thanks, it might be bad for me! Silvio GarattiniVittorio BerteléRita Banzi Point of View 16 September 2012 Pages: 711 - 714
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden Carlo PiccinniEmanuel RaschiFabrizio De Ponti Short Communication 01 September 2012 Pages: 715 - 720
A probable clinically significant interaction between warfarin and cloxacillin: three case reports Hossein KhaliliNaemeh NikvarzSimin Dashti-Khavidaki Short Communication 04 September 2012 Pages: 721 - 724
